Blog Layout

Expanding Access to Rapid HIV & Syphilis Testing in Canada: Trimedic Partners with Medmira

March 13, 2025

Improving early diagnosis, two diseases, one test

At Trimedic, we are committed to improving healthcare access and outcomes through innovative diagnostic solutions. We are proud to announce that Trimedic is now the exclusive commercial partner for Medmira’s HIV and HIV-TP combination tests in Canada. This collaboration will significantly enhance rapid diagnostics for HIV and syphilis, benefiting healthcare providers and patients across the country.


Why This Partnership Matters

Medmira, a Canadian leader in rapid testing technology, has pioneered the Vertical Flow Rapid Test—a groundbreaking approach that delivers highly accurate results within minutes. By bringing these tests to more clinics, hospitals, and community health organizations, Trimedic is ensuring that healthcare providers can quickly diagnose and treat HIV and syphilis, leading to better patient outcomes and improved public health strategies.


The Importance of Rapid Testing

Timely diagnosis is crucial in managing and preventing the spread of infectious diseases like HIV and syphilis. The Medmira HIV and HIV-TP tests offer several key advantages:

  • Immediate results: Clinicians and patients no longer need to wait days for lab results.
  • Increased accessibility: Point-of-care testing reduces barriers to screening, especially in underserved communities.
  • Enhanced efficiency: Faster diagnoses mean quicker treatment initiation, reducing transmission risks and improving patient care.


A Step Forward for Canadian Healthcare

This partnership aligns with Trimedic’s mission to provide cutting-edge diagnostic solutions that empower healthcare providers with the tools they need for efficient and effective disease management. As we expand access to Medmira’s innovative rapid tests, we reinforce our commitment to public health and harm reduction efforts across Canada.

We look forward to working with healthcare professionals, public health organizations, and community clinics to make rapid, reliable, and accessible testing a standard in HIV and syphilis care.


For more information on Medmira’s rapid tests and how to integrate them into your clinical practice, visit Trimedic’s website or contact us today!

By Trimedic December 13, 2024
Reflecting on a Remarkable Year: Trimedic’s 2024 Highlights and a Look Ahead to 2025
By Tom Ostojic November 20, 2024
๐ŸŽ‰ Supporting the 2024 SOGC Contraception Summit! ๐ŸŽ‰
By Tom Ostojic November 14, 2024
Trimedic is thrilled to attend the 2024 CSAM-SMCA Annual Scientific Conference happening from November 14-16, 2024! This important gathering unites Canada’s addiction medicine community to share groundbreaking research, fresh perspectives, and guidance on best practices in addiction care. At Trimedic, we are committed to supporting evidence-based approaches that advance addiction medicine. As we work to enhance harm reduction strategies through reliable diagnostic solutions, we’re excited to engage with industry leaders, learn from new insights, and strengthen our collaborative efforts to make a positive impact on addiction treatment across Canada. We look forward to connecting with peers and gaining invaluable insights to drive our mission forward. Stay tuned for updates on key takeaways and our journey at CSAM-SMCA 2024!
Share by: